• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Jupiter Neurosciences, Inc. - Common Stock (NQ:JUNS)

    0.2324 +0.0028 (+1.22%)
    Streaming Delayed Price Updated: 1:28 PM EDT, Jun 18, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 686,747
    Open 0.2356
    Bid (Size) 0.2290 (5,600)
    Ask (Size) 0.2325 (500)
    Prev. Close 0.2296
    Today's Range 0.2272 - 0.2356
    52wk Range 0.1721 - 3.330
    Shares Outstanding 34,426,355
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    MissionIRNewsBreaks – Jupiter Neurosciences Inc. (NASDAQ: JUNS) Closes $2 Million Registered Direct Offering
    Via Investor Brand Network
    News headline image
    D. Boral Capital Acted as Exclusive Placement Agent to Jupiter Neurosciences, Inc. (Nasdaq:JUNS) in Connection with its ~$2 Million Registered Direct Offering
    Via ACCESS Newswire

    Performance

    YTD
    -77.0%
    -77.0%
    1 Month
    -30.1%
    -30.1%
    3 Month
    -37.2%
    -37.2%
    6 Month
    -79.4%
    -79.4%
    1 Year
    -75.2%
    -75.2%

    More News

    Read More
    What's going on in today's after hours session ↗
    Via Chartmill
    The trading volume of these stocks is deviating from the norm in today's session. ↗
    Via Chartmill
    Most active stocks in Wednesday's session ↗
    Via Chartmill
    Traders are paying attention to the gapping stocks in Wednesday's session. ↗
    Via Chartmill
    Stay updated with the stocks that are on the move in today's pre-market session. ↗
    Via Chartmill
    Top movers in Monday's pre-market session ↗
    Via Chartmill
    News headline image
    Jupiter Neurosciences Investor News: Rosen Law Firm Encourages Jupiter Neurosciences, Inc. Investors to Inquire About Securities Class Action Investigation – JUNS
    From Rosen Law Firm
    Via Business Wire
    News headline image
    Rosen Law Firm Encourages Jupiter Neurosciences, Inc. Investors to Inquire About Securities Class Action Investigation – JUNS
    From The Rosen Law Firm, P.A.
    Via Business Wire
    News headline image
    Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing
    From Virtual Investor Conferences
    Via GlobeNewswire
    News headline image
    Life Sciences Virtual Investor Forum Agenda Announced for March 11th & 12th
    From Virtual Investor Conferences
    Via GlobeNewswire
    News headline image
    Jupiter Neurosciences Selected as B2i Digital Featured Company
    Via NewMediaWire
    News headline image
    Jupiter Neurosciences Selected as B2i Digital Featured Company
    Via TheNewswire.com
    Unusual volume stocks in Thursday's session ↗
    Via Chartmill
    News headline image
    From FDA Clearance To The Launch Of A Consumer Line, Jupiter Neurosciences Hit Milestones In 2025; More On The Horizon
    Via NewMediaWire
    News headline image
    From FDA Clearance To The Launch Of A Consumer Line, Jupiter Neurosciences Hit Milestones In 2025; More On The Horizon
    Via TheNewswire.com
    News headline image
    Jupiter Neurosciences Brings Its Brain Health Expertise To The Masses With Nugevia - And A Range Of Celebs From Athletes To Scientists Are Customers
    Via NewMediaWire
    News headline image
    Jupiter Neurosciences Brings Its Brain Health Expertise To The Masses With Nugevia - And A Range Of Celebs From Athletes To Scientists Are Customers
    Via TheNewswire.com
    News headline image
    Jupiter Neurosciences CEO And President Talk About The Power of JOTROL And The Launch of Its Longevity Consumer Line With Benzinga
    Via TheNewswire.com
    News headline image
    Jupiter Neurosciences CEO And President Talk About The Power of JOTROL And The Launch of Its Longevity Consumer Line With Benzinga
    Via NewMediaWire
    News headline image
    Longevity In A Capsule: Jupiter Neurosciences Launches First Three Supplements Under Nugevia(TM) Brand
    Via NewMediaWire
    News headline image
    Longevity In A Capsule: Jupiter Neurosciences Launches First Three Supplements Under Nugevia(TM) Brand
    Via TheNewswire.com
    News headline image
    There are notable gap-ups and gap-downs in today's session. ↗
    Via Chartmill
    News headline image
    12 Health Care Stocks Moving In Thursday's Intraday Session ↗
    Via Benzinga

    Frequently Asked Questions

    Is Jupiter Neurosciences, Inc. - Common Stock publicly traded?
    Yes, Jupiter Neurosciences, Inc. - Common Stock is publicly traded.
    What exchange does Jupiter Neurosciences, Inc. - Common Stock trade on?
    Jupiter Neurosciences, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Jupiter Neurosciences, Inc. - Common Stock?
    The ticker symbol for Jupiter Neurosciences, Inc. - Common Stock is JUNS on the Nasdaq Stock Market
    What is the current price of Jupiter Neurosciences, Inc. - Common Stock?
    The current price of Jupiter Neurosciences, Inc. - Common Stock is 0.2324
    When was Jupiter Neurosciences, Inc. - Common Stock last traded?
    The last trade of Jupiter Neurosciences, Inc. - Common Stock was at 06/18/26 01:28 PM ET
    What is the market capitalization of Jupiter Neurosciences, Inc. - Common Stock?
    The market capitalization of Jupiter Neurosciences, Inc. - Common Stock is 8.00M
    How many shares of Jupiter Neurosciences, Inc. - Common Stock are outstanding?
    Jupiter Neurosciences, Inc. - Common Stock has 8M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.